Surface modifications of nanocellulose for drug delivery applications; a critical review

dc.contributorAalto-yliopistofi
dc.contributorAalto Universityen
dc.contributor.authorMujtaba, Muhammaden_US
dc.contributor.authorNegi, Arvinden_US
dc.contributor.authorKing, Alistair W.T.en_US
dc.contributor.authorZare, Minaen_US
dc.contributor.authorKuncova-Kallio, Johanaen_US
dc.contributor.departmentDepartment of Bioproducts and Biosystemsen
dc.contributor.groupauthorTextile Chemistryen
dc.contributor.organizationVTT Technical Research Centre of Finlanden_US
dc.contributor.organizationUniversity of Helsinkien_US
dc.contributor.organizationUPM-Kymmeneen_US
dc.date.accessioned2023-08-30T04:21:31Z
dc.date.available2023-08-30T04:21:31Z
dc.date.issued2023-12en_US
dc.descriptionPublisher Copyright: © 2023 The Author(s)
dc.description.abstractWith the development of novel drugs and the discovery of new targets, there is an increased need for novel drug carriers. Nanocellulose has great potential to become a novel drug carrier thanks to its biocompatibility, low toxicity, tunable chemical structure, and sustainability. There are many types of nanocelluloses based on their physical properties (particle size, shape, surface charge), chemical properties (surface functional groups), form (lyophilized, hydrogel, aerogel, membrane) and source (bacterial, animal, plant) and that also largely influences drug release patterns, but also toxicity profile. To our knowledge, so far, no nanocellulose materials have been accepted as ingredients for pharmaceutical formulations. Some types of nanocellulose have however been accepted for use in medical devices, which is also a tightly regulated area. This review focuses on the modification of nanocellulose to enhance its capability as a drug delivery agent and pinpoints the pitfalls for the registration of such novel sustainable material.en
dc.description.versionPeer revieweden
dc.format.mimetypeapplication/pdfen_US
dc.identifier.citationMujtaba, M, Negi, A, King, A W T, Zare, M & Kuncova-Kallio, J 2023, 'Surface modifications of nanocellulose for drug delivery applications; a critical review', Current Opinion in Biomedical Engineering, vol. 28, 100475. https://doi.org/10.1016/j.cobme.2023.100475en
dc.identifier.doi10.1016/j.cobme.2023.100475en_US
dc.identifier.issn2468-4511
dc.identifier.otherPURE UUID: 9e021750-acd6-4fc0-a6bc-71cc23d53bfaen_US
dc.identifier.otherPURE ITEMURL: https://research.aalto.fi/en/publications/9e021750-acd6-4fc0-a6bc-71cc23d53bfaen_US
dc.identifier.otherPURE FILEURL: https://research.aalto.fi/files/119672372/CHEM_Mujtaba_et_al_Surface_modifications_2023_Current_Opinion_in_Biomedical_Engineering.pdf
dc.identifier.urihttps://aaltodoc.aalto.fi/handle/123456789/122992
dc.identifier.urnURN:NBN:fi:aalto-202308305332
dc.language.isoenen
dc.publisherElsevier
dc.relation.ispartofseriesCurrent Opinion in Biomedical Engineeringen
dc.relation.ispartofseriesVolume 28en
dc.rightsopenAccessen
dc.subject.keywordControl drug deliveryen_US
dc.subject.keywordNanocellulose modificationsen_US
dc.subject.keywordPolysaccharidesen_US
dc.subject.keywordSurface modificationen_US
dc.titleSurface modifications of nanocellulose for drug delivery applications; a critical reviewen
dc.typeA2 Katsausartikkeli tieteellisessä aikakauslehdessäfi
dc.type.versionpublishedVersion

Files